3 news items
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
VRNA
9 May 24
will present eight posters including two mini oral symposia, at the American Thoracic Society International Conference ("ATS") 2024. The posters will highlight
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
HTGC
VRNA
9 May 24
and children's aid societies across Ontario. OMERS teams work in Toronto, London, New York, Amsterdam, Luxembourg, Singapore, Sydney and other major cities
Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at ATS 2024
VRNA
2 May 24
with ensifentrine for the treatment of chronic obstructive pulmonary disease ("COPD") will be presented at the American Thoracic Society International
- Prev
- 1
- Next